Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2021
Monthly information related to total number of voting rights and shares composing the…
Month: February 2021
PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings
RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) will release…
Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive…
AGTC Executives Awarded First Place in the BioProcess International Reader’s Choice Awards, Cell & Gene Therapies Category
Article reflects Company’s leadership and innovation in scalable, reproducible manufacture of adeno-associated virus (AAV)-based gene…
EyePoint Pharmaceuticals Announces Closing of $115 Million Public Offering of Common Stock
WATERTOWN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical…
Biogen Announces Cash Tender Offer for 5.200% Senior Notes Due 2045 Open to Certain Holders Only
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced…
Outlook Therapeutics’ Recent Financing Secures Funding to Support ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Through Planned BLA Submission
Overallotment option on recent public offering partially exercised by underwriter Closed concurrent private placement for…
Intrommune Receives IND Clearance From U.S. Food and Drug Administration for INT301
Milestone Marks Advance for Oral Mucosal Immunotherapy for Peanut Allergies NEW YORK, Feb. 04, 2021…
Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
3 out of 4 intubated patients were discharged after treatment 2 out of 4 patients…
Biogen Announces Private Exchange Offer for 5.200% Senior Notes Due 2045 Open to Certain Investors
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced…
ACTIVE BIOTECH ENTERS INTO A MANUFACTURING AGREEMENT WITH FAMAR HEALTH CARE SERVICES FOR NEW FORMULATION OF LAQUINIMOD
Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) today announced it has reached a manufacturing agreement…
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
RP1: Initial data in new indications expected in 2021 in anti-PD1 failed NSCLC, anti-PD1 failed…
Gain Therapeutics Announces Three Late-Breaker Presentations at the 17th Annual WORLDSymposium
BETHESDA, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc., (“Gain”) a biotechnology company…
Turning Point Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days
Company to Participate in Two Q&A Sessions, Including a Joint Discussion with Zai Lab SAN…
GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT)…
CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology Day
SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
Equillium Announces Pricing of $30 Million Registered Direct Offering
LA JOLLA, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ) a clinical-stage…
NKMax America Announces Key Leadership Appointment
SANTA ANA, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — NKMax America, a biotechnology company harnessing…
TCR² Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins its Board of Directors
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR) (“TCR2” or…
Otonomy to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
SAN DIEGO, Feb. 04, 2021 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated…